Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 797

1.

The Authors reply: "Dual energy X-ray absorptiometry: gold standard for muscle mass?" by Scafoglieri et al.

Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Aug 14. doi: 10.1002/jcsm.12329. [Epub ahead of print] No abstract available.

2.

Anticholinergic exposure and cognitive decline in older adults: Effect of anticholinergic exposure definitions in a 3-year analysis of the Multidomain Alzheimer Preventive Trial (MAPT) study.

Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V; MAPT/DSA study group.

Br J Clin Pharmacol. 2018 Aug 10. doi: 10.1111/bcp.13734. [Epub ahead of print]

PMID:
30098049
3.

Designing Drug Trials for Frailty: ICFSR Task Force 2018.

Pahor M, Kritchevsky SB, Waters DL, Villareal DT, Morley J, Hare JM, Vellas B.

J Frailty Aging. 2018;7(3):150-154. doi: 10.14283/jfa.2018.20.

PMID:
30095144
4.

Stability of graph theoretical measures in structural brain networks in Alzheimer's disease.

Mårtensson G, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Volpe G, Westman E.

Sci Rep. 2018 Aug 2;8(1):11592. doi: 10.1038/s41598-018-29927-0.

5.

The exerkine apelin reverses age-associated sarcopenia.

Vinel C, Lukjanenko L, Batut A, Deleruyelle S, Pradère JP, Le Gonidec S, Dortignac A, Geoffre N, Pereira O, Karaz S, Lee U, Camus M, Chaoui K, Mouisel E, Bigot A, Mouly V, Vigneau M, Pagano AF, Chopard A, Pillard F, Guyonnet S, Cesari M, Burlet-Schiltz O, Pahor M, Feige JN, Vellas B, Valet P, Dray C.

Nat Med. 2018 Jul 30. doi: 10.1038/s41591-018-0131-6. [Epub ahead of print]

PMID:
30061698
6.

Vitamin D, homocysteine and n-3PUFA status according to physical and cognitive functions in older adults with subjective memory complaint: Results from cross-sectional study of the MAPT trial.

Chhetri JK, de Souto Barreto P, Soriano G, Gennero I, Cantet C, Vellas B.

Exp Gerontol. 2018 Jul 10;111:71-77. doi: 10.1016/j.exger.2018.07.006. [Epub ahead of print]

PMID:
30006297
7.

What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.

Aisen PS, Siemers E, Michelson D, Salloway S, Sampaio C, Carrillo MC, Sperling R, Doody R, Scheltens P, Bateman R, Weiner M, Vellas B.

J Prev Alzheimers Dis. 2018;5(3):171-174. doi: 10.14283/jpad.2018.23.

PMID:
29972209
8.

Commentary: Fatty acids and Alzheimer's disease: evidence on cognition and cortical β-amyloid from secondary analyses of the Multidomain Alzheimer Preventive Trial.

Hooper C, Vellas B.

J Prev Alzheimers Dis. 2018;5(3):168-170. doi: 10.14283/jpad.2018.7. No abstract available.

PMID:
29972208
9.

Editorial: WHO Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity: The Road for Preventing Cognitive Declines in Older Age?

Vellas B, Scrase D, Rosenberg GA, Andrieu S, Araujo de Carvalho I, Middleton LT.

J Prev Alzheimers Dis. 2018;5(3):165-167. doi: 10.14283/jpad.2018.26. No abstract available.

PMID:
29972207
10.

Associations of Multidomain Lifestyle Intervention with Frailty: Secondary Analysis of a Randomized Controlled Trial.

de Souto Barreto P, Rolland Y, Maltais M, Vellas B; MAPT Study Group.

Am J Med. 2018 Jul 1. pii: S0002-9343(18)30548-5. doi: 10.1016/j.amjmed.2018.06.002. [Epub ahead of print]

PMID:
29969614
11.

Neural correlates of episodic memory in the Memento cohort.

Epelbaum S, Bouteloup V, Mangin JF, La Corte V, Migliaccio R, Bertin H, Habert MO, Fischer C, Azouani C, Fillon L, Chupin M, Vellas B, Pasquier F, Dartigues JF, Blanc F, Gabelle A, Ceccaldi M, Krolak-Salmon P, Hugon J, Hanon O, Rouaud O, David R, Chêne G, Dubois B, Dufouil C.

Alzheimers Dement (N Y). 2018 May 22;4:224-233. doi: 10.1016/j.trci.2018.03.010. eCollection 2018.

12.

Telemedicine for the management of neuropsychiatric symptoms in long-term care facilities: the DETECT study, methods of a cluster randomised controlled trial to assess feasibility.

Piau A, Nourhashemi F, De Mauléon A, Tchalla A, Vautier C, Vellas B, Duboue M, Costa N, Rumeau P, Lepage B, Soto Martin M.

BMJ Open. 2018 Jun 12;8(6):e020982. doi: 10.1136/bmjopen-2017-020982.

13.

Six-month observational follow-up on activities of daily living in people with dementia living in nursing homes after a 6-month group based on either exercise or social activities.

Maltais M, Rolland Y, Haÿ PE, Armaingaud D, Vellas B, de Souto Barreto P.

Aging Clin Exp Res. 2018 Jun 7. doi: 10.1007/s40520-018-0984-z. [Epub ahead of print]

PMID:
29876831
14.

Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.

Chhetri JK, de Souto Barreto P, Cantet C, Pothier K, Cesari M, Andrieu S, Coley N, Vellas B.

J Alzheimers Dis. 2018;64(1):71-78. doi: 10.3233/JAD-180209.

PMID:
29865075
15.

Burden of Frailty in Post-Disaster Low-Income Countries: An Example From Nepal.

Chhetri JK, Mahara G, Vellas B, Cesari M.

Disaster Med Public Health Prep. 2018 May 30:1. doi: 10.1017/dmp.2018.50. [Epub ahead of print] No abstract available.

PMID:
29843831
16.

Interventions Against Disability in Frail Older Adults: Lessons Learned from Clinical Trials.

Fougère B, Morley JE, Little MO, De Souto Barreto P, Cesari M, Vellas B.

J Nutr Health Aging. 2018;22(6):676-688. doi: 10.1007/s12603-017-0987-z.

PMID:
29806856
17.

How to Manage Frail Older Adults in the Community? Proposal of a Health Promotion Program Experienced in a City of 16,638 Inhabitants in France.

de Kerimel J, Tavassoli N, Lafont C, Soto M, Pedra M, Nourhashemi F, Lagourdette C, Bouchon L, Chaléon A, Sourdet S, Rolland Y, Cesari M, Vellas B.

J Frailty Aging. 2018;7(2):120-126. doi: 10.14283/jfa.2017.47.

PMID:
29741197
18.

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.

Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Harper Mozley L, Vandenberghe R, Mo Y, Michelson D.

N Engl J Med. 2018 May 3;378(18):1691-1703. doi: 10.1056/NEJMoa1706441.

PMID:
29719179
19.

Editorial: Involving Primary Care Health Professionals in Geriatric Assessment.

Fougère B, Cesari M, Arai H, Woo J, Merchant RA, Flicker L, Cherubini A, Bauer JM, Vellas B, Morley JE.

J Nutr Health Aging. 2018;22(5):566-568. doi: 10.1007/s12603-018-1001-0. No abstract available.

PMID:
29717754
20.

Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults with subjective memory complaints.

Hooper C, De Souto Barreto P, Cantet C, Cesari M, Payoux P, Salabert AS, Vellas B; MAPT/DSA study group.

Exp Gerontol. 2018 Jul 15;108:226-230. doi: 10.1016/j.exger.2018.04.014. Epub 2018 Apr 25.

PMID:
29704641
21.

Factors predisposing nursing home resident to inappropriate transfer to emergency department. The FINE study protocol.

Perrin A, Tavassoli N, Mathieu C, Hermabessière S, Houles M, McCambridge C, Magre E, Fernandez S, Caquelard A, Charpentier S, Lauque D, Azema O, Bismuth S, Chicoulaa B, Oustric S, Costa N, Molinier L, Vellas B, Bérard E, Rolland Y.

Contemp Clin Trials Commun. 2017 Jul 21;7:217-223. doi: 10.1016/j.conctc.2017.07.005. eCollection 2017 Sep.

22.

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia.

Nourhashemi F, Hooper C, Cantet C, Féart C, Gennero I, Payoux P, Salabert AS, Guyonnet S, De Souto Barreto P, Vellas B; Multidomain Alzheimer Preventive Trial/Data sharing Alzheimer (DSA) study group.

Alzheimers Res Ther. 2018 Apr 25;10(1):43. doi: 10.1186/s13195-018-0371-1.

23.

Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task Force.

Cummings J, Fox N, Vellas B, Aisen P, Shan G.

J Prev Alzheimers Dis. 2018;5(2):103-109. doi: 10.14283/jpad.2018.13.

PMID:
29616703
24.

Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force.

Sano M, Soto M, Carrillo M, Cummings J, Hendrix S, Mintzer J, Porsteinsson A, Rosenberg P, Schneider L, Touchon J, Aisen P, Vellas B, Lyketsos C.

J Prev Alzheimers Dis. 2018;5(2):98-102. doi: 10.14283/jjpad.2018.15.

PMID:
29616702
25.

Diabetes Mellitus and Cognitive Decline - Prevention Should Not Be Delayed!

Sinclair AJ, Vellas B.

J Prev Alzheimers Dis. 2018;5(2):95-97. doi: 10.14283/jpad.2018.9. No abstract available.

PMID:
29616701
26.

Editorial: Prevention of Alzheimer's Disease in Chinese Populations: Status, Challenges and Directions.

Feng L, Li J, Yu JT, Zhang C, Yang B, Vellas B, Li C.

J Prev Alzheimers Dis. 2018;5(2):90-94. doi: 10.14283/jpad.2018.14. No abstract available.

PMID:
29616700
27.

Involvement of Advanced Practice Nurse in the Management of Geriatric Conditions: Examples from Different Countries.

Fougère B, Lagourdette C, Abele P, Resnick B, Rantz M, Kam Yuk Lai C, Chen Q, Moyle W, Vellas B, Morley JE.

J Nutr Health Aging. 2018;22(4):463-470. doi: 10.1007/s12603-018-1008-6.

PMID:
29582884
28.

Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study.

Rapp T, Andrieu S, Chartier F, Deberdt W, Reed C, Belger M, Vellas B.

Value Health. 2018 Mar;21(3):295-303. doi: 10.1016/j.jval.2017.09.019. Epub 2017 Nov 11.

PMID:
29566836
29.

Prospective associations between white matter hyperintensities and lower extremity function.

Moon SY, de Souto Barreto P, Rolland Y, Chupin M, Bouyahia A, Fillon L, Mangin JF, Andrieu S, Cesari M, Vellas B; MAPT/DSA Study Group.

Neurology. 2018 Apr 10;90(15):e1291-e1297. doi: 10.1212/WNL.0000000000005289. Epub 2018 Mar 9.

PMID:
29523640
30.

Physical Activity and Changes in White Matter Hyperintensities over Three Years.

Moon SY, de Souto Barreto P, Cesari M, Chupin M, Mangin JF, Bouyahia A, Fillon L, Andrieu S, Vellas B.

J Nutr Health Aging. 2018;22(3):425-430. doi: 10.1007/s12603-017-0959-3.

PMID:
29484357
31.

Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care.

Rouch L, Farbos F, Cool C, McCambridge C, Hein C, Elmalem S, Rolland Y, Vellas B, Cestac P.

J Nutr Health Aging. 2018;22(3):328-334. doi: 10.1007/s12603-017-0940-1.

PMID:
29484345
32.

Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.

Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Tréluyer JM, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert PH, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group.

Alzheimers Dement. 2018 Jul;14(7):858-868. doi: 10.1016/j.jalz.2018.01.004. Epub 2018 Feb 17.

33.

Heterogeneous patterns of brain atrophy in Alzheimer's disease.

Poulakis K, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E.

Neurobiol Aging. 2018 May;65:98-108. doi: 10.1016/j.neurobiolaging.2018.01.009. Epub 2018 Jan 31.

PMID:
29455029
34.

Untangling the overlap between frailty and low lean mass: Data from Toulouse frailty day hospital.

Fougère B, Sourdet S, Lilamand M, Tabue-Teguod M, Teysseyre B, Dupuy C, Vellas B, Rolland Y, Nourhashemi F, van Kan GA.

Arch Gerontol Geriatr. 2018 Mar - Apr;75:209-213. doi: 10.1016/j.archger.2017.12.013. Epub 2017 Dec 29.

PMID:
29426485
35.

An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017.

Sinclair AJ, Abdelhafiz A, Dunning T, Izquierdo M, Rodriguez Manas L, Bourdel-Marchasson I, Morley JE, Munshi M, Woo J, Vellas B.

J Frailty Aging. 2018;7(1):10-20. doi: 10.14283/jfa.2017.39. Review.

PMID:
29412437
36.

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, Cruz-Jentoft AJ, Del Signore S, Donahue S, Morley J, Pahor M, Reginster JY, Rodriguez Mañas L, Rolland Y, Roubenoff R, Sinclair A, Cesari M.

J Frailty Aging. 2018;7(1):2-9. doi: 10.14283/jfa.2017.30.

PMID:
29412436
37.

Evidence for The Domains Supporting The Construct of Intrinsic Capacity.

Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Cooper C, Martin FC, Reginster JY, Vellas B, Beard JR.

J Gerontol A Biol Sci Med Sci. 2018 Feb 2. doi: 10.1093/gerona/gly011. [Epub ahead of print]

PMID:
29408961
38.

The Relationship of Omega 3 Polyunsaturated Fatty Acids in Red Blood Cell Membranes with Cognitive Function and Brain Structure: A Review Focussed on Alzheimer's Disease.

Hooper C, De Souto Barreto P, Pahor M, Weiner M, Vellas B.

J Prev Alzheimers Dis. 2018;5(1):78-84. doi: 10.14283/jpad.2017.19.

PMID:
29405237
39.

Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials.

Chhetri JK, de Souto Barreto P, Cantet C, Cesari M, Coley N, Andrieu S, Vellas B.

J Prev Alzheimers Dis. 2018;5(1):31-35. doi: 10.14283/jpad.2017.21.

PMID:
29405230
40.

Frailty Screening (FRAIL-NH) and Mortality in French Nursing Homes: Results From the Incidence of Pneumonia and Related Consequences in Nursing Home Residents Study.

De Silva TR, Theou O, Vellas B, Cesari M, Visvanathan R.

J Am Med Dir Assoc. 2018 May;19(5):411-414. doi: 10.1016/j.jamda.2017.12.101.

PMID:
29402647
41.

Editorial: Geriatrics in the 21st Century.

Vellas B, Morley JE.

J Nutr Health Aging. 2018;22(2):186-190. doi: 10.1007/s12603-017-0988-y. No abstract available.

PMID:
29380844
42.

Impact of diabetes on caregiver stress in patients with Alzheimer's disease: data from the ICTUS study.

Li J, Cesari M, Del Campo N, Andrieu S, Dong B, Lim WS, Vellas B.

Int Psychogeriatr. 2018 Jan 30:1-9. doi: 10.1017/S1041610217002460. [Epub ahead of print]

PMID:
29380719
43.

A web-based multidomain lifestyle intervention with connected devices for older adults: research protocol of the eMIND pilot randomized controlled trial.

Pothier K, Soriano G, Lussier M, Naudin A, Costa N, Guyonnet S, Piau A, Ousset PJ, Nourhashemi F, Vellas B, de Souto Barreto P.

Aging Clin Exp Res. 2018 Sep;30(9):1127-1135. doi: 10.1007/s40520-018-0897-x. Epub 2018 Jan 24.

PMID:
29368298
44.

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.

Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M, Dean RA, Hake A, Sundell K, Poole Hoffmann V, Carlson C, Khanna R, Mintun M, DeMattos R, Selzler KJ, Siemers E.

N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971.

45.

Pitfalls in the measurement of muscle mass: a need for a reference standard.

Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):269-278. doi: 10.1002/jcsm.12268. Epub 2018 Jan 19.

46.

Chronic inflammation and sarcopenia: A regenerative cell therapy perspective.

Chhetri JK, de Souto Barreto P, Fougère B, Rolland Y, Vellas B, Cesari M.

Exp Gerontol. 2018 Mar;103:115-123. doi: 10.1016/j.exger.2017.12.023. Epub 2018 Jan 10.

PMID:
29331536
47.

Association between Red Blood Cells Omega-3 Polyunsaturated Fatty Acids and White Matter Hyperintensities: The MAPT Study.

Moon SY, de Souto Barreto P, Chupin M, Mangin JF, Bouyahia A, Fillon L, Andrieu S, Vellas B.

J Nutr Health Aging. 2018;22(1):174-179. doi: 10.1007/s12603-017-0965-5.

PMID:
29300438
48.

Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study.

Costa N, Wübker A, De Mauléon A, Zwakhalen SMG, Challis D, Leino-Kilpi H, Hallberg IR, Stephan A, Zabalegui A, Saks K, Molinier L, Wimo A, Vellas B, Sauerland D, Binot I, Soto ME; RightTimePlaceCare consortium.

J Am Med Dir Assoc. 2018 Jan;19(1):95.e1-95.e10. doi: 10.1016/j.jamda.2017.10.013.

PMID:
29275939
49.

Poor cognitive ageing: Vulnerabilities, mechanisms and the impact of nutritional interventions.

Miquel S, Champ C, Day J, Aarts E, Bahr BA, Bakker M, Bánáti D, Calabrese V, Cederholm T, Cryan J, Dye L, Farrimond JA, Korosi A, Layé S, Maudsley S, Milenkovic D, Mohajeri MH, Sijben J, Solomon A, Spencer JPE, Thuret S, Vanden Berghe W, Vauzour D, Vellas B, Wesnes K, Willatts P, Wittenberg R, Geurts L.

Ageing Res Rev. 2018 Mar;42:40-55. doi: 10.1016/j.arr.2017.12.004. Epub 2017 Dec 15. Review.

50.

Exercise training for preventing dementia, mild cognitive impairment, and clinically meaningful cognitive decline: a systematic review and meta-analysis.

Barreto PS, Demougeot L, Vellas B, Rolland Y.

J Gerontol A Biol Sci Med Sci. 2017 Dec 5. doi: 10.1093/gerona/glx234. [Epub ahead of print]

PMID:
29216339

Supplemental Content

Loading ...
Support Center